304 related articles for article (PubMed ID: 17149983)
1. Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species.
Jobling MF; Mott JD; Finnegan MT; Jurukovski V; Erickson AC; Walian PJ; Taylor SE; Ledbetter S; Lawrence CM; Rifkin DB; Barcellos-Hoff MH
Radiat Res; 2006 Dec; 166(6):839-48. PubMed ID: 17149983
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
Ghahary A; Tredget EE; Shen Q
J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
[TBL] [Abstract][Full Text] [Related]
3. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical localization of latent transforming growth factor-beta1 activation by stimulated macrophages.
Chong H; Vodovotz Y; Cox GW; Barcellos-Hoff MH
J Cell Physiol; 1999 Mar; 178(3):275-83. PubMed ID: 9989773
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D3 metabolites regulate LTBP1 and latent TGF-beta1 expression and latent TGF-beta1 incorporation in the extracellular matrix of chondrocytes.
Pedrozo HA; Schwartz Z; Mokeyev T; Ornoy A; Xin-Sheng W; Bonewald LF; Dean DD; Boyan BD
J Cell Biochem; 1999 Jan; 72(1):151-65. PubMed ID: 10025676
[TBL] [Abstract][Full Text] [Related]
6. Redox-mediated activation of latent transforming growth factor-beta 1.
Barcellos-Hoff MH; Dix TA
Mol Endocrinol; 1996 Sep; 10(9):1077-83. PubMed ID: 8885242
[TBL] [Abstract][Full Text] [Related]
7. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
Ghahary A; Tredget EE; Mi L; Yang L
Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
[TBL] [Abstract][Full Text] [Related]
8. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes.
Chen Y; Ali T; Todorovic V; O'leary JM; Kristina Downing A; Rifkin DB
J Mol Biol; 2005 Jan; 345(1):175-86. PubMed ID: 15567420
[TBL] [Abstract][Full Text] [Related]
9. A possible role of vimentin on the cell surface for the activation of latent transforming growth factor-beta.
Nishida Y; Shibata K; Yamasaki M; Sato Y; Abe M
FEBS Lett; 2009 Jan; 583(2):308-12. PubMed ID: 19121313
[TBL] [Abstract][Full Text] [Related]
10. The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo.
Sullivan DE; Ferris M; Pociask D; Brody AR
J Immunotoxicol; 2008 Apr; 5(2):145-9. PubMed ID: 18569384
[TBL] [Abstract][Full Text] [Related]
11. Role of carbohydrate structures in the binding of beta1-latency-associated peptide to ligands.
Yang Y; Dignam JD; Gentry LE
Biochemistry; 1997 Sep; 36(39):11923-32. PubMed ID: 9305986
[TBL] [Abstract][Full Text] [Related]
12. Regulation of transforming growth factor beta1 by nitric oxide.
Vodovotz Y; Chesler L; Chong H; Kim SJ; Simpson JT; DeGraff W; Cox GW; Roberts AB; Wink DA; Barcellos-Hoff MH
Cancer Res; 1999 May; 59(9):2142-9. PubMed ID: 10232601
[TBL] [Abstract][Full Text] [Related]
13. Retinal and choroidal TGF-beta in the tree shrew model of myopia: isoform expression, activation and effects on function.
Jobling AI; Wan R; Gentle A; Bui BV; McBrien NA
Exp Eye Res; 2009 Mar; 88(3):458-66. PubMed ID: 19046968
[TBL] [Abstract][Full Text] [Related]
14. Heparin inhibits activation of latent transforming growth factor-β1.
Lee MJ
Pharmacology; 2013; 92(5-6):238-44. PubMed ID: 24247664
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of retinoid-induced activation of latent transforming growth factor-beta in bovine endothelial cells.
Kojima S; Rifkin DB
J Cell Physiol; 1993 May; 155(2):323-32. PubMed ID: 8482724
[TBL] [Abstract][Full Text] [Related]
16. Deficient transforming growth factor-beta1 activation and excessive insulin-like growth factor II (IGFII) expression in IGFII receptor-mutant tumors.
Wang S; Souza RF; Kong D; Yin J; Smolinski KN; Zou TT; Frank T; Young J; Flanders KC; Sugimura H; Abraham JM; Meltzer SJ
Cancer Res; 1997 Jul; 57(13):2543-6. PubMed ID: 9205049
[TBL] [Abstract][Full Text] [Related]
17. Involvement of UVB-induced reactive oxygen species in TGF-beta biosynthesis and activation in keratinocytes.
Wang H; Kochevar IE
Free Radic Biol Med; 2005 Apr; 38(7):890-7. PubMed ID: 15749385
[TBL] [Abstract][Full Text] [Related]
18. Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship.
Wipff PJ; Hinz B
Eur J Cell Biol; 2008 Sep; 87(8-9):601-15. PubMed ID: 18342983
[TBL] [Abstract][Full Text] [Related]
19. P311 binds to the latency associated protein and downregulates the expression of TGF-beta1 and TGF-beta2.
Paliwal S; Shi J; Dhru U; Zhou Y; Schuger L
Biochem Biophys Res Commun; 2004 Mar; 315(4):1104-9. PubMed ID: 14985127
[TBL] [Abstract][Full Text] [Related]
20. Effects of TGF-betas and a specific antagonist on apoptosis of immature rat male germ cells in vitro.
Konrad L; Keilani MM; Laible L; Nottelmann U; Hofmann R
Apoptosis; 2006 May; 11(5):739-48. PubMed ID: 16532270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
